Department of Medical Sciences, University of Milan, Endocrine Unit, Istituto Clinico Humanitas IRCCS, Via Manzoni 56, 20089 Rozzano, Italy.
Best Pract Res Clin Endocrinol Metab. 2012 Aug;26(4):395-403. doi: 10.1016/j.beem.2011.10.009. Epub 2012 May 22.
The widespread use of sensitive neuroradiological imaging studies (i.e. computed tomography scan and magnetic resonance imaging) over the last years lead to the diagnosis of an increased number of asymptomatic pituitary lesions. The management of these so-called "pituitary incidentalomas" is still controversial, due to the limited data so far available on both the clinical relevance and the natural history of such incidentally discovered pituitary masses. Most pituitary incidentalomas are less than 1 cm in diameter (microincidentalomas) and are pituitary adenomas. Although these tumours are in general hormonally inactive, all the patients with incidentalomas should be screened for pituitary hypo- or hyper-function. Macroincidentalomas have greater growth potential and, when associated with hypopituitarism and/or visual disturbances, should be surgically removed. Conversely, incidentalomas not associated with hormonal alterations and dimensionally stable could be managed conservatively. This review will focus on the last data on the natural history and clinical management of pituitary incidentalomas.
近年来,敏感的神经影像学研究(即计算机断层扫描和磁共振成像)的广泛应用导致了越来越多无症状垂体病变的诊断。由于迄今为止关于这些偶然发现的垂体肿块的临床相关性和自然史的数据有限,这些所谓的“垂体偶发瘤”的处理仍存在争议。大多数垂体偶发瘤直径小于 1 厘米(微偶发瘤),是垂体腺瘤。尽管这些肿瘤通常无激素活性,但所有偶发瘤患者都应筛查垂体功能减退或亢进。大偶发瘤有更大的生长潜力,当与垂体功能减退和/或视力障碍相关时,应进行手术切除。相反,与激素改变和尺寸稳定无关的偶发瘤可以保守治疗。本综述将重点介绍垂体偶发瘤自然史和临床管理的最新数据。